Purchase Order 75N95024P00332
- Not listed
- This is a $190,080.00 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a 5-year maintenance agreement on a BD Biosciences Aria Fusion flow cytometry instrument. The original sources sought notice indicated the government was looking for a small business capable of providing maintenance services for flow cytometry equipment used in biomedical research. However, the...
- This is a $217,295.28 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a maintenance agreement covering BD Biosciences Symphony S6 and S5 flow cytometry instruments. The award is a follow-on to a request for quotes (RFQ) under simplified acquisition procedures and is not set aside for small businesses. BD, a global medical technology company, is the prime...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract, valued at $620,350.80, is for extended warranty maintenance support for BD's flow cytometry equipment, including the FACSAria II, FACSCanto II, FACSAria Fusion, and FACS Symphony A3 systems. The contract has a period of performance through July 11, 2027. This award was not set aside for...
- This is a $15,822.00 firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson and Company (BD) for service and maintenance of a BD A1 Symphony flow cytometer. The contract is for a 1-year period of performance from June 1, 2024 to June 2, 2025. No set-aside was used for this award. BD is a major medical technology company that provides a range of products and services to...
- This is a $1,994,840.77 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance services on various government-owned BD flow cytometry equipment over the base period ending on July 1, 2026. BD is a global medical technology company that specializes in flow cytometry, cell imaging, and...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for an annual maintenance agreement on two flow cytometers. The contract has a ceiling value of $7,068.00 and an ultimate completion date of January 30, 2016. BD is a major manufacturer and supplier of medical devices, instruments, reagents, and related products to government agencies,...
- The National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $76,248.00 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for a service agreement to maintain a FACSymphony S6 flow cytometer sorter and associated laser equipment. The contract runs from February 1, 2025 to January 31, 2026 and includes two preventive maintenance inspections per year, unlimited service visits, and 48-hour emergency response. This procurement was...
- This is a $93,978.96 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance services on a BD FACSymphony A5 flow cytometer and associated instrumentation. The contract is for a base period ending on March 31, 2024, with no set-aside designation. The contract was awarded without competition under simplified acquisition procedures for commercial items, as the NCI...
- This contract is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Becton, Dickinson and Company (BD), a global medical technology manufacturer. The purpose is to provide a maintenance and service agreement for BD's custom FACSYMPHONY A5 flow cytometer used by NINDS's Viral Immunology and Intravital Imaging Section. The contract has a potential value of...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging, a civilian agency, to Becton, Dickinson And Company (BD) for maintenance and repair services on BD Biosciences flow cytometry instruments and associated systems. The $166,971.60 contract has an ultimate completion date of March 31, 2029. BD is a global medical technology company that provides a wide range of products and services to federal agencies, including the Department of Veterans Affairs, National...
This is a $86,575.68 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for service and maintenance on a BD A1 Symphony flow cytometry instrument. The contract has a term of approximately 4 years, with a completion date of June 12, 2028. BD, through its BDB Division and BD Biosciences brand, is a global medical technology company that specializes in flow cytometry and other advanced biomedical research instrumentation and services. This contract supports ongoing maintenance and upkeep of a critical laboratory instrument used in NIA research programs. The award does not utilize any set-aside designations, indicating BD's competitive position in providing these specialized services to federal agencies. BD holds several significant federal Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the NIH and Department of Veterans Affairs for flow cytometry equipment, reagents, and related support, demonstrating its strategic positioning in the government medical technology market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $21.6k | 5/15/25 | |
| Not listed | Not listed | $21.6k | 6/13/24 |